About
Kevin Eggan is a stem cell and regenerative biology scientist known for work on neurodegenerative disease, cellular reprogramming, and therapeutic stem cell applications. BioMarin announced in 2020 that he joined the company as Group Vice President and Head of Research and Early Development, while QurAlis lists him as a founder and Scientific Advisory Board member. He is also a 2006 MacArthur Fellow, and MIT Biology identifies him as a Harvard professor.
Areas of interest
biotechstem cell biologygenetic medicinesrare diseasesALSneurodegenerative diseasesRNA therapeuticsdrug discovery